British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...
It's been more than a year since the Food and Drug Administration approved the first vaccine to treat RSV. Since then, newly ...
Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory ...
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.
From next year, pregnant women across Australia could receive a free vaccine to protect their babies against the potentially dangerous illness RSV There's been more than 150 000 reported cases ...
October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.
That’s short for respiratory syncytial virus. Almost all children will get RSV during their first two years, but each year up to 80,000 children are hospitalized due to it. Now, a new FDA approved ...
The respiratory syncytial virus (RSV) can be particularly dangerous for older people with chronic medical conditions. Each ...
Growing up in Amsterdam, The Netherlands, Louis Bont's father who worked at the Netherlands Cancer Institute (NKI), often ...
The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...